| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |